Yanfeng Hou: Clinical Trials

3 trials sponsored by Yanfeng Hou, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Yanfeng Hou: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on Lymphocyte Subsets of Peripheral Blood in Patients With Nonmyopathic Dermatomyositis Complicated With Pulmonary Interstitial Disease
Dermatomyositis
UnknownYanfeng Hou1202023-04-012023-11-28
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
Telitacicept, Systemic Lupus Erythematosus
UnknownYanfeng Hou502022-11-012023-11-21
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
Iguratimod - Rheumatoid Arthritis, Therapy
Phase 4UnknownYanfeng Hou1172021-06-012024-03-25

Conditions studied

Arthritis, Rheumatoid (1)  ·  Dermatomyositis (1)  ·  Lupus Erythematosus, Systemic (1)

Interventions

iguratimod (1)  ·  tofacitinib (1)

Countries

China (3)